{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:47:01Z","timestamp":1786985221835,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006606","name":"Natural Science Foundation of Tianjin Municipality","doi-asserted-by":"publisher","award":["23JCZXJC00150"],"award-info":[{"award-number":["23JCZXJC00150"]}],"id":[{"id":"10.13039\/501100006606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006606","name":"Natural Science Foundation of Tianjin Municipality","doi-asserted-by":"publisher","award":["23JCJQJC00040"],"award-info":[{"award-number":["23JCJQJC00040"]}],"id":[{"id":"10.13039\/501100006606","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bioorg.2026.109892","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T23:14:06Z","timestamp":1776467646000},"page":"109892","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Pyrimethamine regulates m6A modification of CCND1 via METTL14\/YTHDF2 to inhibit hepatocellular carcinoma"],"prefix":"10.1016","volume":"176","author":[{"given":"Xiao","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kailong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caiyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangshuang","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guixiang","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bioorg.2026.109892_bb0005","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"6","key":"10.1016\/j.bioorg.2026.109892_bb0010","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.21873\/anticanres.12612","article-title":"In vitro and in vivo antitumor effects of pyrimethamine on non-small cell lung cancers","volume":"38","author":"Lin","year":"2018","journal-title":"Anticancer Res"},{"issue":"1","key":"10.1016\/j.bioorg.2026.109892_bb0015","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s13046-016-0409-9","article-title":"New derivatives of the antimalarial drug pyrimethamine in the control of melanoma tumor growth: an in vitro and in vivo study","volume":"35","author":"Tommasino","year":"2016","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.bioorg.2026.109892_bb0020","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1158\/1541-7786.MCR-08-0263","article-title":"Antifolate activity of pyrimethamine enhances temozolomide-induced cytotoxicity in melanoma cells","volume":"7","author":"Chen","year":"2009","journal-title":"Mol. Cancer Res."},{"issue":"6","key":"10.1016\/j.bioorg.2026.109892_bb0025","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.1007\/s11033-022-07262-y","article-title":"Pyrimethamine inhibits cell growth by inducing cell senescence and boosting CD8(+) T-cell mediated cytotoxicity in colorectal cancer","volume":"49","author":"Dong","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.bioorg.2026.109892_bb0030","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.00758","article-title":"Pyrimethamine elicits antitumor effects on prostate cancer by inhibiting the p38-NF-\u03baB pathway","volume":"11","author":"Zhou","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"15","key":"10.1016\/j.bioorg.2026.109892_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22158147","article-title":"Pyrimethamine modulates interplay between apoptosis and autophagy in chronic myelogenous leukemia cells","volume":"22","author":"Jung","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.bioorg.2026.109892_bb0040","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1101\/gad.7.5.812","article-title":"Cyclin D1 is a nuclear protein required for cell cycle progression in G1","volume":"7","author":"Baldin","year":"1993","journal-title":"Genes Dev."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109892_bb0045","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/hep.29781","article-title":"Hepatocellular carcinoma-related cyclin D1 is selectively regulated by autophagy degradation system","volume":"68","author":"Wu","year":"2018","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.bioorg.2026.109892_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25020981","article-title":"BMP9-ID1 pathway attenuates N(6)-methyladenosine levels of cyclinD1 to promote cell proliferation in hepatocellular carcinoma","volume":"25","author":"Chen","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.bioorg.2026.109892_bb0055","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.3324\/haematol.2021.279739","article-title":"YTHDF3 modulates hematopoietic stem cells by recognizing RNA m(6)A modification on Ccnd1","volume":"107","author":"Zhang","year":"2022","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.bioorg.2026.109892_bb0060","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s13046-020-01714-8","article-title":"RNA N6-methyladenosine reader IGF2BP3 regulates cell cycle and angiogenesis in colon cancer","volume":"39","author":"Yang","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.bioorg.2026.109892_bb0065","doi-asserted-by":"crossref","first-page":"6251","DOI":"10.1093\/nar\/gkaa347","article-title":"Dynamic landscape and evolution of m6A methylation in human","volume":"48","author":"Zhang","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109892_bb0070","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-019-1033-z","article-title":"The role of m(6)a RNA methylation in human cancer","volume":"18","author":"Chen","year":"2019","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.bioorg.2026.109892_bb0075","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13578-020-00513-0","article-title":"Biological functions of m(6)a methyltransferases","volume":"11","author":"Gu","year":"2021","journal-title":"Cell Biosci."},{"key":"10.1016\/j.bioorg.2026.109892_bb0080","article-title":"m6A epitranscriptomic modification in hepatocellular carcinoma: implications for the tumor microenvironment and immunotherapy","volume":"16","author":"Liu","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bioorg.2026.109892_bb0085","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.984453","article-title":"The role of RNA modification in hepatocellular carcinoma","volume":"13","author":"Feng","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109892_bb0090","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1146\/annurev-biochem-072324-031915","article-title":"DNA damage and replication stress checkpoints","volume":"94","author":"Yates","year":"2025","journal-title":"Annu. Rev. Biochem."},{"issue":"12","key":"10.1016\/j.bioorg.2026.109892_bb0095","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1101\/gad.13.12.1501","article-title":"CDK inhibitors: positive and negative regulators of G1-phase progression","volume":"13","author":"Sherr","year":"1999","journal-title":"Genes Dev."},{"issue":"8","key":"10.1016\/j.bioorg.2026.109892_bb0100","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nrc3090","article-title":"Cyclin D as a therapeutic target in cancer","volume":"11","author":"Musgrove","year":"2011","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.bioorg.2026.109892_bb0105","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/jcp.21791","article-title":"Nuclear cyclin D1: an oncogenic driver in human cancer","volume":"220","author":"Kim","year":"2009","journal-title":"J. Cell. Physiol."},{"issue":"12","key":"10.1016\/j.bioorg.2026.109892_bb0110","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s00109-016-1475-3","article-title":"Cyclin D1, cancer progression, and opportunities in cancer treatment","volume":"94","author":"Qie","year":"2016","journal-title":"J. Mol. Med."},{"issue":"4","key":"10.1016\/j.bioorg.2026.109892_bb0115","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.4049\/jimmunol.133.4.1710","article-title":"Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67","volume":"133","author":"Gerdes","year":"1984","journal-title":"J. Immunol."},{"issue":"7481","key":"10.1016\/j.bioorg.2026.109892_bb0120","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature12730","article-title":"N6-methyladenosine-dependent regulation of messenger RNA stability","volume":"505","author":"Wang","year":"2014","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.bioorg.2026.109892_bb0125","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109892_bb0130","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s12672-025-02198-8","article-title":"Advancements and limitations in traditional anti-cancer therapies: a comprehensive review of surgery, chemotherapy, radiation therapy, and hormonal therapy","volume":"16","author":"Zafar","year":"2025","journal-title":"Discov. Oncol."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109892_bb0135","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/HM9.0000000000000104","article-title":"The evolution and significance of medicine and food homology","volume":"4","author":"Zhong","year":"2024","journal-title":"Acupunct. Herb. Med."},{"issue":"4","key":"10.1016\/j.bioorg.2026.109892_bb0140","doi-asserted-by":"crossref","DOI":"10.1007\/s00262-026-04351-w","article-title":"Metformin drives HIF-1\u03b1-mediated dual metabolic reprogramming to enhance \u03b3\u03b4 T cell therapy in triple-negative breast cancer","volume":"75","author":"Qin","year":"2026","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.bioorg.2026.109892_bb0145","doi-asserted-by":"crossref","DOI":"10.1007\/s12015-026-11102-y","article-title":"Combined treatment of metformin with frankincense essential oil or manuka honey synergistically inhibited stemness characteristics, enhanced sensitivity, and induced apoptosis in the CD44+\/CD24(-\/low) breast cancer stem subpopulation","author":"Abouelnazar","year":"2026","journal-title":"Stem Cell Rev. Rep."},{"key":"10.1016\/j.bioorg.2026.109892_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2026.218311","article-title":"SLC5A11 mediates metformin-induced PD-L1 suppression to enhance cancer immunotherapy through AMPK-IRF1 signaling","volume":"644","author":"Ma","year":"2026","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109892_bb0155","doi-asserted-by":"crossref","first-page":"46","DOI":"10.21608\/ejhm.2026.476526","article-title":"Evaluation of metformin in combination with neoadjuvant therapy in breast cancer patients","volume":"102","author":"Hegazy","year":"2026","journal-title":"Egypt. J. Hosp. Med."},{"issue":"8","key":"10.1016\/j.bioorg.2026.109892_bb0160","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/S1470-2045(25)00231-1","article-title":"Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol","volume":"26","author":"Gillessen","year":"2025","journal-title":"Lancet Oncol."},{"issue":"3","key":"10.1016\/j.bioorg.2026.109892_bb0165","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1158\/1535-7163.MCT-18-0936","article-title":"Antimalarial drug pyrimethamine plays a dual role in antitumor proliferation and metastasis through targeting DHFR and TP","volume":"18","author":"Liu","year":"2019","journal-title":"Mol. Cancer Ther."},{"issue":"12","key":"10.1016\/j.bioorg.2026.109892_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25122763","article-title":"Anticancer activity of pyrimethamine via ubiquitin mediated degradation of AIMP2-DX2","volume":"25","author":"Kim","year":"2020","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.bioorg.2026.109892_bb0175","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70232","article-title":"METTL14-mediated m6A modification of ZFP14 inhibits clear cell renal cell carcinoma progression via promoting STAT3 ubiquitination","volume":"15","author":"Liu","year":"2025","journal-title":"Clin. Transl. Med."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109892_bb0180","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12943-020-01220-7","article-title":"METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer","volume":"19","author":"Chen","year":"2020","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.bioorg.2026.109892_bb0185","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/s12967-025-06241-8","article-title":"JMJD6 K375 acetylation restrains lung cancer progression by enhancing METTL14\/m6A\/SLC3A2 axis mediated cell ferroptosis","volume":"23","author":"Chen","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bioorg.2026.109892_bb0190","article-title":"The dual regulatory role of METTL14-mediated m(6)A modification in tumorigenesis and its underlying mechanisms","volume":"16","author":"Yang","year":"2026","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.bioorg.2026.109892_bb0195","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13045-022-01231-5","article-title":"Functions, mechanisms, and therapeutic implications of METTL14 in human cancer","volume":"15","author":"Guan","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bioorg.2026.109892_bb0200","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12626","article-title":"YTHDF2 destabilizes m(6)A-containing RNA through direct recruitment of the CCR4-NOT deadenylase complex","volume":"7","author":"Du","year":"2016","journal-title":"Nat. Commun."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826004281?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826004281?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T00:56:30Z","timestamp":1778720190000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826004281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":40,"alternative-id":["S0045206826004281"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109892","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pyrimethamine regulates m6A modification of CCND1 via METTL14\/YTHDF2 to inhibit hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109892","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109892"}}